Evaluation on Pfizer’s Distribution Strategy
Introduction
The case study presented the prevailing problems experienced by the ranchers in their Calf/Cattle production. The dominant problems encountered by various ranchers in their production of high-quality livestock rooted in the control of meatpackers and the NAFTA agreement with other nations producing and importing livestock to the U.S territory, making the domestic industry crippled under distribution process and high income-driven business.
The situation analyzed in the case study provides us a glimpse of the changing strategies and tactics in the industry to cope with the demands of the time. However, the center stage always boils down to consumers’ needs. This determinant allows the producers of any livestock to adapt effective ways and tactics in order to make it more appealing and highly qualified products.
The presence of commercial imports coming from different countries like Mexico, Canada, and Australia make ranchers develop practical means in order to effectively compete against the import production of the same products. Moreover, the inevitability of such problems which caused the domestic producers of livestock generates low-grade income due to low-quality production medicated by Pfizer’s highly-caliber animal health care products. The highly researched health products of Pfizer provide producers or ranchers solutions to the prevalent problems in livestock industry. This help ranchers or producers compete with the quality of products imported from different countries under NAFTA’s agreement.
Pfizer’s Distribution Strategy
Pfizer’s strategic modes in my own evaluation and analysis are both effective and ineffective. The effectiveness of such distribution scheme varied accordingly. In this case study, the researchers outlined Pfizer’s distribution strategy as both effective and ineffective in some extent. Clearly, the indirect distribution of products to the ranchers itself manifests an effective strategy to further improve and generate high sales production. In this sense, Pfizer’s friendly business strategy allows an effective promotion of their animal health care products. The use of intermediaries in selling their products reinforces products quality. Such for instance, veterinarians are used by the company to promote and sell their products in exchange for incentives and great benefits. Analyzed based on thorough research, this strategic plan found out to be effective since ranchers in their emphasis of producing high-quality production of calves/cattle submit to the importance of health care lifestyle of their livestock which lead them to consult with expertise like veterinarians. With this demand, though, veterinarians do not directly sell products yet significant in its promotion.
In this case, because ranchers and producers greatly adhere mostly with veterinarians’ medical expertise are easily persuaded in choosing preferences on health products. The reliance of ranchers and producers to veterinarians’ knowledge effectively promotes Pfizer’s products. However, let us not give chauvinistic calculations about this fact, matter of fact; Pfizer’s inclination to highly-based research programs produces high-quality results.
It should be taken into account the changing environment in the production of various commercial products to be more attractive in the eyes of consumers. Henceforth, improvements in genetics and animal health and nutrition allowed producers/ranchers or owners of livestock production to increase production yields even with fewer head. In this case study, researchers presented the changing of consumers’ preferences and tastes with regards to food and lifestyle. This matter affects much of the livestock production especially the beef production in commercial markets. However, in order to make an effective appeal to consumers, changing of product packages style should be considered. Accordingly, branded products are more attractive to consumers because of the preconditioned assumption of ‘high-quality’. This situation calls in re-directing the emphasis in producing high-quality products in this case, the health, nutritional, and genetic improvements plays a significant role.
Pfizer’s distribution strategy on the other hand, does not deem to create unhealthy competition against other corporations of the same field. However, the baseline of such unhealthiness competition and ineffectiveness strategic plans is situated on distributors/dealers business schemes. Although the case study only provides a little amount of explanation and exemplification of such scheme, it still concretized something which is important. Distributors/dealers strategic planning shows ineffective strategy of the Pfizer itself, although, offers some trade promotions to vets and distributors however, the ineffectiveness rested on competitors’ offers of much more significant discounts which resulted to distributors’ profiteering. Since, much profit is acquired from Pfizer’s competitors’ of the same product, distributors always falls down into this scheme, and make Pfizer’s strategy ineffective.
What remedy can we prescribe out of this scheme is that to program and formulate new strategic plans in which no fatal compromises will affect the productions of goods. The solution can only be identified out of thorough research and understanding of the cases. The ineffectiveness resulted from Pfizer’s trust to distributors’ management scheme without knowledge of any infidelity just to gain more profit. Pfizer should look into this account and formulate better solution to remedy such cases, moreover, to take risk of providing attractive benefits, incentives, and promotions to distributors to avoid fatal injury in their market production.
Conclusion
This evaluation is based on the given case study about Pfizer’s distribution strategy amidst the prevailing problems in the domestic production of livestock. Pfizer’s promotions of animal health care products give domestic producers chances to compete with imported producers on the level of quality control. Although, Pfizer’s medical products are more effective compared to other competitors, the ineffective distribution strategy tempered its rapid increase of profit or income and its production due to distributors/dealers business schemes. Nevertheless, if and when this global corporation will look deeply into this case, it will eventually medicate and prevent fatal injury on their production of goods.
Credit:ivythesis.typepad.com
0 comments:
Post a Comment